Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.

The British journal of ophthalmology - 1 Nov 2001

Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin P G

Abstract excerpt

AIMS: To determine whether plasma homocysteine, methylene tetrahydrofolate reductase (MTHFR) C677T and factor II G20210A polymorphisms, factor VIII, and vWF are risk factors for central retinal vein occlusion (CRVO). METHOD: Prospective comparison of 63 consecutive patients with central retinal v...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Enzyme-Linked Immunosorbent Assay
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Homocysteine

Share to Methylenetetrahydrofolate Dehydrogenase (NADP)

Share to Prothrombin

Share to Retinal Vein Occlusion

Share to von Willebrand Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 11673296
DOI: 10.1136/bjo.85.11.1313
PMCID: PMC1723784

Genes

MTHFR
VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11673296-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.PMID 11673296Read ↗

Plasma homocysteine in patients with retinal vein occlusion.Semantic proximity Read ↗

Thrombophilic risk factors in patients with central retinal vein occlusion.Semantic proximity Read ↗

Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.Semantic proximity Read ↗

Thrombophilia in patients with retinal vein occlusion: a retrospective analysis.Semantic proximity Read ↗

Hyperhomocysteinemia in central retinal vein occlusion in young adults.Semantic proximity Read ↗

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.Semantic proximity Read ↗

Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion.Semantic proximity Read ↗

Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.Semantic proximity Read ↗

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis.Semantic proximity Read ↗

Thrombophilic mutations and risk of retinal vein occlusion.Semantic proximity Read ↗

Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.Semantic proximity Read ↗

The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.